885521-34-6 Usage
General Description
3-Bromo-6-chloro-1H-indazole is a chemical compound with the molecular formula C7H4BrClN2. It is a heterocyclic compound belonging to the indazole class and contains a bromine and chlorine atom attached to the indazole ring. 3-Bromo-6-chloro-1H-indazole is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various pharmaceutical drugs. It is also utilized in organic chemistry research and serves as a building block for the creation of new chemical compounds. Additionally, 3-Bromo-6-chloro-1H-indazole has potential applications in agrochemicals and material science due to its structural properties and reactivity. As a result, it is an important chemical in the field of organic synthesis and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 885521-34-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,5,2 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 885521-34:
(8*8)+(7*8)+(6*5)+(5*5)+(4*2)+(3*1)+(2*3)+(1*4)=196
196 % 10 = 6
So 885521-34-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrClN2/c8-7-5-2-1-4(9)3-6(5)10-11-7/h1-3H,(H,10,11)
885521-34-6Relevant articles and documents
EHPATITIS B ANTIVIRAL AGENTS
-
Page/Page column 44-45, (2016/11/28)
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A-Y-Z-L-R1 (I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
ALPHA 7 NICOTINIC ACETYLCHOLINE ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF
-
, (2013/12/03)
The present application is related to compounds represented by Formula I, which are novel positive allosteric modulators of al nAChRs. The application also discloses the treatment of disorders that are responsive to enhancement of acetylcholine action on al nAChRs in a mammal by administering an effective amount of a compound of Formula I.
